RIZZI, Michele
 Distribuzione geografica
Continente #
NA - Nord America 477
EU - Europa 84
AS - Asia 70
Totale 631
Nazione #
US - Stati Uniti d'America 477
CN - Cina 45
UA - Ucraina 23
GB - Regno Unito 20
DE - Germania 15
TR - Turchia 13
SG - Singapore 12
SE - Svezia 9
FI - Finlandia 6
IT - Italia 5
BE - Belgio 3
AT - Austria 1
DK - Danimarca 1
FR - Francia 1
Totale 631
Città #
Fairfield 69
Woodbridge 62
Houston 49
Chandler 43
Ashburn 38
Jacksonville 30
Seattle 24
Cambridge 21
Ann Arbor 20
Wilmington 18
San Diego 13
Beijing 12
Nanjing 11
New York 8
Boardman 7
Izmir 7
Princeton 7
Shanghai 6
Addison 5
Los Angeles 5
Bremen 3
Brussels 3
Shenyang 3
Singapore 3
Changsha 2
Falls Church 2
Jiaxing 2
Jinan 2
Nanchang 2
Orange 2
San Mateo 2
Tianjin 2
Washington 2
Acton 1
Auburn Hills 1
Chicago 1
Fuzhou 1
Guangdong 1
Kunming 1
London 1
Miami 1
Philadelphia 1
Simi Valley 1
Verona 1
Vienna 1
Wakefield 1
Totale 498
Nome #
Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity 119
Novel terphenyls and 3,5-diaryl isoxazole derivatives endowed with growth supporting and antiapoptotic properties 116
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 109
Novel combretastatin analogues endowed with antitumor activity 101
The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: Analysis of the possible molecular basis 98
Antitumor effects of curcumin and structurally β-diketone modified analogs on multidrug resistant cancer cells 93
Totale 636
Categoria #
all - tutte 2.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.817


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020127 0 7 5 23 11 18 14 13 15 11 8 2
2020/202167 6 5 3 8 2 9 2 11 1 9 7 4
2021/202280 3 6 11 2 3 2 6 2 4 4 7 30
2022/202392 6 6 5 12 16 13 0 11 16 2 5 0
2023/202451 1 5 2 3 6 16 0 3 2 1 0 12
2024/20256 2 4 0 0 0 0 0 0 0 0 0 0
Totale 636